08.07.2024
This may look like any child, any family, any weekend. A dad and mom sharing the excitement of their daughter, little hands grasping a new toy, eyes wide with curiosity at the tiny image on the camera screen. What you can't see is that this little girl, Ipek, has a fatal genetic disease - ataxia telangiectasia, or AT - which eventually robs children of their ability to read and write, slurs their speech, confines them to wheelchairs and makes them highly likely to get regular lung infections that don't respond to antibiotics and malignant cancers like lymphoma and leukemia. Children with AT often don't survive their teenage years, at most into their twenties.
But Ipek received a highly targeted genetic treatment at just three years old and became the second child after Mila to receive an individualized medicine. Four years have gone by, and although regular injections and hospital monitoring are the price to pay, Ipek's life is more normal than what it should be.
It's moments like these that give us hope that we can find and treat children like Mila and Ipek in time so that they and their families never know life with disease.